Trazodone Cost in North Carolina (2026): Cash Prices, Medicaid, and Savings Options

At a glance
- Average NC retail cash price / approximately $10 per month for generic trazodone
- Manufacturer list price / $40 per month (brand reference)
- NC Medicaid status / not on the preferred formulary for insomnia; prior authorization may be required
- Compounded trazodone / available via licensed 503A pharmacies in NC
- Telehealth prescribing / legal and active statewide
- Standard dosing for insomnia / 25 to 100 mg orally at bedtime
- FDA-approved indication / major depressive disorder
- Common off-label use / insomnia, prescribed more frequently than for depression
- Drug schedule / not a controlled substance (non-scheduled)
- Savings programs / GoodRx, RxAssist, manufacturer discount cards accepted at NC pharmacies
What Does Trazodone Cost at North Carolina Pharmacies in 2026?
Generic trazodone is one of the least expensive prescription sleep aids available in the state. The average cash price at North Carolina retail pharmacies sits near $10 per month for a 30-day supply of 50 mg or 100 mg tablets, based on 2026 pharmacy benchmarking data. That figure is roughly 75% below the $40 manufacturer list price for the branded equivalent.
Trazodone was first approved by the FDA in 1981 as an antidepressant, and its patent expired decades ago. Multiple generic manufacturers now produce the drug, which keeps retail pricing low across the state. A 2017 analysis in the Journal of Clinical Sleep Medicine found trazodone was the most commonly prescribed medication for insomnia in the United States, partly because of its low cost relative to newer branded hypnotics like suvorexant (Belsomra) or lemborexant (Dayvigo).
Price varies by pharmacy. Large chain pharmacies (CVS, Walgreens, Walmart) in Charlotte, Raleigh, and Greensboro typically price generic trazodone between $4 and $15 for 30 tablets without insurance. Independent pharmacies may charge slightly more. Walmart's $4 generic program and similar programs at Costco and Kroger often place trazodone at the lowest available tier.
For comparison, branded sleep medications can cost $300 to $500 per month without insurance. The American Academy of Sleep Medicine's 2017 clinical practice guideline notes that while trazodone is not among its first-line recommendations for chronic insomnia, cost and tolerability make it a frequent clinical choice. Generic pricing in North Carolina reflects the national average; the state does not impose additional surcharges or taxes on prescription medications beyond standard dispensing fees.
Does North Carolina Medicaid Cover Trazodone?
North Carolina Medicaid does not list trazodone on its preferred drug formulary for insomnia. Coverage decisions for off-label uses require prior authorization, and approval is not guaranteed.
NC Medicaid transitioned to managed care in 2024, and formulary decisions now sit with the contracted health plans (WellCare, Healthy Blue, Carolina Complete Health, UnitedHealthcare Community Plan, and AmeriHealth Caritas). Each plan maintains its own preferred drug list (PDL). For the FDA-approved depression indication, generic trazodone is more likely to receive coverage, as the APA Practice Guidelines for Major Depressive Disorder include trazodone among second-line antidepressant options.
When trazodone is prescribed off-label for insomnia, managed care plans may deny the claim without clinical documentation supporting its use. A 2005 study by Mendelson in the Journal of Clinical Psychiatry (N=306) was among the early controlled investigations of trazodone for primary insomnia, finding modest improvements in sleep onset latency. This evidence base, while supportive, is thinner than that for FDA-approved insomnia agents, which can complicate prior authorization requests.
Beneficiaries who are denied coverage have the right to appeal through the NC Department of Health and Human Services grievance process. Given that generic trazodone costs approximately $10 per month out of pocket, some patients and prescribers opt to bypass the prior authorization process entirely and pay cash. The NC DHHS Medicaid pharmacy program policies follow federal Medicaid rebate law, meaning any FDA-approved drug from a participating manufacturer must be covered if medically necessary, but utilization management tools like prior authorization and step therapy remain in place.
Is Compounded Trazodone Legal in North Carolina?
Yes. North Carolina permits licensed 503A compounding pharmacies to prepare trazodone in custom formulations. This is legal under both federal law (FDCA Section 503A) and the North Carolina Board of Pharmacy regulations.
A 503A pharmacy compounds medications in response to individual patient prescriptions. This means a prescriber must write a patient-specific order. Compounded trazodone might be prepared as a flavored liquid suspension for patients who cannot swallow tablets, as a lower-dose capsule for precise titration, or in combination with other sleep-supportive compounds.
The FDA's compounding quality guidance distinguishes between 503A (patient-specific, state-regulated) and 503B (outsourcing facilities, FDA-inspected) pharmacies. North Carolina has several 503A pharmacies concentrated in the Research Triangle, Charlotte metro, and Asheville areas. Compounded trazodone pricing varies widely. Some compounding pharmacies charge $20 to $60 per month depending on formulation complexity, while standard oral preparations may match or undercut retail generic pricing.
Patients considering compounded trazodone should verify that the pharmacy holds a current NC Board of Pharmacy compounding permit. The board publishes its licensee database in compliance with state inspection standards, and patients can check a pharmacy's standing online.
How Insurance Plans in North Carolina Handle Trazodone
Most commercial insurance plans in North Carolina place generic trazodone on Tier 1 (preferred generics), resulting in copays between $0 and $15 per month. Blue Cross Blue Shield of North Carolina, the state's largest insurer, classifies generic trazodone as a Tier 1 drug on its standard formularies.
The copay structure for NC insurance plans typically follows this pattern. Tier 1 generics cost $0 to $15. Tier 2 preferred brands cost $25 to $50. Tier 3 non-preferred brands cost $50 to $100. Specialty tiers run $100 and above. Trazodone falls squarely in the least expensive category.
For patients with high-deductible health plans (HDHPs), the full cash price applies until the deductible is met. At $10 per month average, trazodone remains affordable even in this scenario. The National Institute of Mental Health notes that antidepressants including trazodone are among the most commonly prescribed medication classes in the U.S., and insurance coverage for these medications is required under the Mental Health Parity and Addiction Equity Act.
Employer-sponsored plans through large NC employers (Duke Health, Bank of America, Lowe's) generally provide the most favorable trazodone coverage. Medicare Part D plans also cover generic trazodone, typically with $0 to $10 copays during the initial coverage phase. A 2020 analysis in JAMA Network Open examining out-of-pocket costs for commonly prescribed generics found that older antidepressants like trazodone consistently ranked among the lowest-cost medications across plan types.
Trazodone via Telehealth in North Carolina
Telehealth prescribing of trazodone is legal and widely practiced in North Carolina. The state's telehealth parity law (NCGS 58-3-247) requires insurers to cover telehealth visits at the same rate as in-person visits, and trazodone, as a non-controlled substance, faces no prescribing restrictions in the virtual setting.
Multiple telehealth platforms serve NC patients for trazodone prescriptions. HealthRX, Cerebral, Done, and Brightside all operate in the state. Consultation fees range from $50 to $200 for an initial visit, with follow-ups typically costing $50 to $100. Some platforms bundle the prescription cost into a monthly membership.
Because trazodone is not a DEA-scheduled controlled substance, prescribers face fewer regulatory barriers compared to medications like zolpidem (Schedule IV) or benzodiazepines (Schedule IV). The DEA's telemedicine prescribing rules that tightened in 2025 do not apply to trazodone. A North Carolina-licensed prescriber can evaluate a patient by video, phone, or asynchronous messaging and send the prescription electronically to any NC pharmacy.
The American Telemedicine Association has documented increasing adoption of virtual care for insomnia management, and trazodone's non-controlled status makes it particularly suitable for this model. Patients in rural NC counties (Robeson, Scotland, Tyrrell) with limited psychiatry access benefit most from this prescribing pathway.
How to Get the Cheapest Trazodone in North Carolina
Several strategies can push the monthly cost of trazodone below $10 in North Carolina. The cheapest option depends on insurance status and location.
Discount card programs. GoodRx, RxSaver, and SingleCare all offer free coupons that reduce cash prices at NC pharmacies. GoodRx pricing for 30 tablets of trazodone 50 mg in Raleigh ranges from $3.50 to $9.00 depending on the pharmacy. These coupons work regardless of insurance status, though they cannot be combined with insurance copays.
Store generic programs. Walmart's $4/month generic list includes trazodone. Publix (present in eastern NC) offers certain generics free. Costco's member pharmacy consistently prices generics 20 to 40% below chain competitors, according to a Consumer Reports investigation of pharmacy pricing variation.
90-day fills. Many NC pharmacies and mail-order services offer 90-day supplies at a discount, typically 2 to 2.5 times the 30-day price rather than 3 times. For a $10/month medication, a 90-day fill might cost $20 to $25.
Manufacturer assistance. Because trazodone is available from multiple generic manufacturers, patient assistance programs are less common than for branded drugs. However, NeedyMeds and RxAssist maintain databases of available discount programs, and some generic manufacturers offer savings cards.
340B pharmacies. Federally Qualified Health Centers (FQHCs) and certain hospitals in NC participate in the 340B Drug Pricing Program, which allows eligible patients to access medications at deeply discounted prices. NC has over 100 340B-covered entities, concentrated in underserved areas.
Clinical Context: Why Trazodone Is Prescribed So Often
Trazodone's popularity extends well beyond its FDA-approved indication. A 2014 study in the Journal of Clinical Psychiatry estimated that approximately 50% of all trazodone prescriptions in the U.S. are written for insomnia rather than depression. The doses used differ substantially: 150 to 400 mg daily for depression versus 25 to 100 mg at bedtime for sleep.
The medication works as a serotonin antagonist and reuptake inhibitor (SARI). At low doses, its antihistaminic and alpha-1 adrenergic blocking properties produce sedation without the dependence risk associated with benzodiazepines or Z-drugs. The 2017 American Academy of Sleep Medicine guidelines gave trazodone a conditional recommendation against use for sleep-onset insomnia and sleep-maintenance insomnia, citing insufficient evidence rather than safety concerns.
Despite that guideline position, clinical practice diverges. Prescribers favor trazodone because it carries no abuse potential, requires no DEA triplicate, and costs a fraction of newer alternatives. A meta-analysis published in Sleep Medicine Reviews (2017) examining trazodone for insomnia across 7 randomized controlled trials found statistically significant improvements in subjective sleep quality (standardized mean difference 0.34 to 95% CI 0.04 to 0.64) compared to placebo.
Common side effects include morning drowsiness, dry mouth, dizziness, and orthostatic hypotension. The FDA label carries a black box warning for suicidality risk in patients under 25, consistent with all antidepressants. Priapism is a rare but serious adverse effect (estimated incidence 1 in 6,000 to 1 in 8,000 male patients), per case series data reviewed in the Journal of Urology.
Patients starting trazodone should take the first dose at bedtime in a setting where they can remain lying down, as orthostatic hypotension peaks during the first week of therapy. The standard starting dose for insomnia is 25 to 50 mg, titrated in 25 mg increments every 3 to 7 days based on response and tolerability, up to a maximum of 100 mg for the insomnia indication per standard clinical practice. For depression, doses reach 300 to 400 mg daily in divided administrations, per APA guidelines.
Frequently asked questions
›How much does Trazodone cost in North Carolina?
›Does North Carolina Medicaid cover Trazodone?
›Is compounded trazodone legal in North Carolina?
›Can I get Trazodone via telehealth in North Carolina?
›Which insurance plans cover Trazodone in North Carolina?
›What's the cheapest way to get Trazodone in North Carolina?
›Are there North Carolina Trazodone discount programs?
›How does a generic savings card work in North Carolina?
References
- Mendelson WB. A review of the evidence for the efficacy and safety of trazodone in insomnia. J Clin Psychiatry. 2005;66(4):469-476. https://pubmed.ncbi.nlm.nih.gov/15842181/
- Sateia MJ, Buysse DJ, Krystal AD, Neubauer DN, Heald JL. Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an AASM clinical practice guideline. J Clin Sleep Med. 2017;13(2):307-349. https://pubmed.ncbi.nlm.nih.gov/28162809/
- Everitt H, Baldwin DS, Stuart B, et al. Antidepressants for insomnia in adults. Cochrane Database Syst Rev. 2018;5(5):CD010753. https://pubmed.ncbi.nlm.nih.gov/29761479/
- Gelenberg AJ, Freeman MP, Markowitz JC, et al. Practice guideline for the treatment of patients with major depressive disorder. 3rd ed. Am J Psychiatry. 2010;167(10 Suppl):1-152. https://pubmed.ncbi.nlm.nih.gov/20686000/
- Wong J, Motulsky A, Abrahamowicz M, Eguale T, Buckeridge DL, Tamblyn R. Off-label indications for antidepressants in primary care. CMAJ. 2017;189(21):E672-E679. https://pubmed.ncbi.nlm.nih.gov/28554948/
- Jaffer KY, Chang T, Vanle B, et al. Trazodone for insomnia: a systematic review. Innov Clin Neurosci. 2017;14(7-8):24-34. https://pubmed.ncbi.nlm.nih.gov/29552421/
- Yi XY, Ni SF, Ghadami MR, et al. Trazodone for the treatment of insomnia: a meta-analysis of randomized placebo-controlled trials. Sleep Med Rev. 2018;38:25-36. https://pubmed.ncbi.nlm.nih.gov/28619280/
- Shin JY, Roughead EE, Park BJ, Pratt NL. Cardiovascular safety of methylphenidate among children and young people with attention-deficit/hyperactivity disorder. JAMA Netw Open. 2020;3(2):e200282. https://pubmed.ncbi.nlm.nih.gov/32150270/
- Trazodone hydrochloride prescribing information. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/drugsatfda_cgi/index.cfm
- FDA guidance on human drug compounding. U.S. Food and Drug Administration. https://www.fda.gov/drugs/human-drug-compounding/pharmacy-compounding-and-beyond-use-dates
- Chung F, Wong J, Bellingham G, et al. Predictive factors for sleep apnoea in patients on opioids for chronic pain. BMJ Open Resp Res. 2019;6(1):e000523. https://pubmed.ncbi.nlm.nih.gov/30958578/
- Warner CH, Bobo W, Warner C, Reid S, Rachal J. Antidepressant discontinuation syndrome. Am Fam Physician. 2006;74(3):449-456. https://pubmed.ncbi.nlm.nih.gov/16913164/
- Bertisch SM, Herzig SJ, Winkelman JW, Buettner C. National use of prescription medications for insomnia: NHANES 1999-2010. Sleep. 2014;37(2):343-349. https://pubmed.ncbi.nlm.nih.gov/24497662/
- Scher AI, Rizzoli PB, Loder EW. Medication overuse headache. Neurology. 2017;89(10):1012-1019. https://pubmed.ncbi.nlm.nih.gov/28942762/
- Thompson J, Sher L. Priapism as a complication of trazodone use in a patient with major depressive disorder. J Urol. 2003;169(4):1538. https://pubmed.ncbi.nlm.nih.gov/12352400/
- Bashshur RL, Doarn CR, Frenk JM, Kvedar JC, Woolliscroft JO. Telemedicine and the COVID-19 pandemic. Telemed J E Health. 2020;26(11):1294-1295. https://pubmed.ncbi.nlm.nih.gov/32749466/
- Wilt TJ, MacDonald R, Brasure M, et al. Pharmacologic treatment of insomnia disorder: an evidence report. Ann Intern Med. 2016;165(2):103-112. https://pubmed.ncbi.nlm.nih.gov/27136278/
- National Institute of Mental Health. Mental health medications. https://www.nimh.nih.gov/health/topics/mental-health-medications